Observational Safety Study of Clottafact® Fibrinogen Concentrate: Real-World Data in Mexico

The use of fibrinogen concentrate to treat or prevent major bleeding with regard to potential adverse reactions has not been free of controversy. Our objective was to perform a post-authorization safety study to describe the use of Clottafact® (LFB Biomedicaments) fibrinogen concentrate in real-life medical practice in Mexico. This was a prospective, observational study that collected and evaluated information between January 2017 and June 2019...